RETATRUTIDE 30MG

Retatrutide (30MG) is a first-in-class triple agonist peptide targeting GIP, GLP-1, and
glucagon receptors simultaneously. This advanced research compound enables investigation of
complex multi-receptor signaling interactions and synergistic metabolic pathway activation.
Supplied as lyophilized white powder at ≥99% purity (HPLC verified). Designed for in vitro studies
investigating receptor co-activation dynamics, energy metabolism pathways, and comparative
receptor agonist pharmacology. Store at -20°C to -80°C sealed, or 2-8°C reconstituted for up to
28 days.
This product is sold strictly for research purposes. Not intended for human or animal use.
Not FDA-approved.